Suppr超能文献

负载载体的大鼠红细胞在体内的存活及器官摄取情况。

In vivo survival and organ uptake of loaded carrier rat erythrocytes.

作者信息

Alvarez F J, Herráez A, Murciano J C, Jordán J A, Díez J C, Tejedor M C

机构信息

Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Universidad de Alcalá de Henares, Madrid, Spain.

出版信息

J Biochem. 1996 Aug;120(2):286-91. doi: 10.1093/oxfordjournals.jbchem.a021411.

Abstract

Rat RBCs loaded with 125I-CA by hypotonic dialysis and isotonic resealing were evaluated as a carrier system. Loaded RBCs stored at 4 degrees C remained unlysed (90% survival) allowing release of encapsulated 125I-CA for up to 4 days. Thereafter, cellular lysis increased significantly. IP-injected loaded RBCs reached the maximum level (50%) in circulation at 24 h post-injection. Circulating loaded RBCs showed a half-life of 8-10 days, which was advantageous for carrier function. In contrast to IP-injected free CA, which remained in circulation for only a short time, encapsulated CA showed significant levels in circulation up to 10 days post-injection. The profile of organ uptake with time is essentially not altered for loaded with respect to native cells, being higher the removal of loaded cells and mainly localized in spleen. Nevertheless, liver is the organ with highest elimination capacity for both native and loaded cells, showing its maximum at 24 h post-injection. Concomitantly, the concentration of 125I-CA in all organs studied was highest at this time. These data demonstrate that rat loaded RBCs can potentially be used as a carrier system for long-term dissemination of drug into the organism, with specially increased delivery to the spleen. They also support the use of the rat as an experimental model for biochemical and pharmacological studies in these therapeutic systems.

摘要

通过低渗透析和等渗重封加载125I-儿茶酚胺(CA)的大鼠红细胞被评估为一种载体系统。加载后的红细胞在4℃储存时未发生裂解(存活率90%),封装的125I-CA可持续释放4天。此后,细胞裂解显著增加。腹腔注射加载后的红细胞在注射后24小时在循环中达到最高水平(50%)。循环中的加载红细胞半衰期为8 - 10天,这对载体功能有利。与腹腔注射的游离CA仅在循环中停留很短时间不同,封装的CA在注射后10天内在循环中仍保持显著水平。加载细胞与天然细胞相比,各器官摄取随时间的变化情况基本未改变,加载细胞的清除率更高,主要定位于脾脏。然而,肝脏是天然细胞和加载细胞清除能力最高的器官,在注射后24小时达到最大值。与此同时,此时所有研究器官中125I-CA的浓度最高。这些数据表明,加载后的大鼠红细胞有可能作为一种载体系统,用于将药物长期输送到机体中,特别是增加对脾脏的递送。它们还支持将大鼠用作这些治疗系统中生化和药理学研究的实验模型。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验